Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07598383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

Name: A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis — clinical trial record (NCT07598383)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorJiangsu vcare pharmaceutical technology co., LTD

Started2026-06-01

View on ClinicalTrials.gov ↗

Amendment history

2026-07-03

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-05-30→confirmed 2026-06-01

Study sitesdetails revised at 1 of 1 site

2026-05-14

Original filing

Jiangsu vcare pharmaceutical technology co., LTD

17 trials monitored

See all monitored trials

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

This is a multicenter, randomized, double-blind, vehicle controlled phase II clinical study to evaluate the efficacy and safety of VC005 gel in adult subjects with mild to moderate atopic dermatitis

Trial Details

NCT Number	NCT07598383
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Atopic Dermatitis
Enrollment	120 participants
Start Date	2026-06-01
Primary Completion	2027-02-22 (estimated)
Study Completion	2027-02-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-07